Transcutaneous electrical nerve stimulation for chronic Graft-Versus-Host disease patients

未提供0 个研究点目标入组 30 人开始时间: 待定

适应症

试验速览

暂无简介。

•Patients with chronic GVHD who are receiving outpatient care or hospitalized at Hokkaido University Hospital or Sapporo hokuyu Hospital between the date of implementation approval and January 31, 2028

•Patients meeting any of the following criteria will be excluded from the study:
•Patients with a history of progressive brain lesions.
•Patients concurrently receiving Vagus Nerve Stimulation (VNS) therapy.
•Patients with a history of severe cardiovascular disease.
•Patients with a history of hypersensitivity to glycerin.
•Patients with a confirmed recurrence of a malignant tumor.
•Patients who are pregnant or breastfeeding.
•Patients with difficulty in oral intake.
•Patients with a history of dermatological reactions to metals or other substances.
•Patients with an implanted cardiac pacemaker or an implantable cardioverter-defibrillator (ICD).
•Any other patients deemed unsuitable for the study by the Principal Investigator or Sub-investigator.

发起方

未提供